SYK
US EQUITY
Health Care
Health Care Equipment
CIK: 310764
Stryker Corporation (SYK) Quant Factor Diagnostic & Fair Value Model
Stryker Corporation (Ticker: SYK) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$307.15
+0.02%
Latest Close (2026-10-23)
Market Cap: $116.79B
P/E Ratio: 23.3
Momentum Strength
3M / 12M
-8.79%
1M: +13.86%
12M: -20.91%
Quality (ROE)
Point-in-Time
+21.28%
Trailing Return on Equity
Technical Trend
RSI 14
69.2
SMA50: $295.80
SMA200: $325.30
Valuation Multiplier
Trailing
23.3
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
SYK trades within a typical sector multiple band (23.3x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 310764 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-07-31 | $6.59B | $1.28B | $1.84B | $3.30 |
| 10-Q | 2025-12-31 | 2026-07-31 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-07-31 | $6.02B | $884.00M | $1.36B | $2.29 |
| 10-Q | 2026-03-31 | 2026-05-11 | $6.02B | $745.00M | $581.00M | $1.93 |
| 10-Q | 2025-03-31 | 2026-05-11 | $5.87B | $654.00M | $250.00M | $1.69 |
| 10-K | 2025-12-31 | 2026-02-11 | $7.17B | $849.00M | $5.04B | $2.20 |
| 10-K | 2025-09-30 | 2026-02-11 | $6.06B | $859.00M | - | $2.22 |
| 10-K | 2025-06-30 | 2026-02-11 | $6.02B | $884.00M | - | $2.29 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Stryker Corporation (SYK) valuation multiples, momentum factors, and point-in-time filing conventions.
How should SYK's current valuation multiple be interpreted? ↓
SYK trades at a trailing P/E of 23.3x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are SYK's key momentum and technical factor indicators? ↓
As of the latest close, SYK shows a 1-month return of +13.86%, 3-month return of -8.79%, and 12-month return of -20.91%, with a 14-day RSI of 69.2. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for SYK? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can SYK be incorporated into systematic factor models? ↓
SYK can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.